Minireviews
Copyright ©The Author(s) 2021.
World J Gastroenterol. Oct 14, 2021; 27(38): 6387-6398
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6387
Figure 3
Figure 3 Structures of agents that target downregulation of Sp1, Sp3 and Sp4 in pancreatic and other cancer cell lines[68]. The structurally diverse compounds act through multiple pathways in different cancer cell lines.